About CRIL
CRIL is a company based in Cambridge (United Kingdom) founded in 2018 by Giulio Cerullo. CRIL has raised $1.7 million across 8 funding rounds from investors including Frontier IP, European Union and Graphene Flagship. The company has 1 employees as of January 31, 2022. CRIL offers products and services including STRALE, CHAMP, and CORAL. CRIL operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.
- Headquarter Cambridge, United Kingdom
- Employees 1 as on 31 Jan, 2022
- Founders Giulio Cerullo
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cambridge Raman Imaging Ltd
- Date of Incorporation 15 Mar, 2018
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.7 M (USD)
in 8 rounds
-
Latest Funding Round
$1.38 M (USD), Seed
May 24, 2022
-
Investors
Frontier IP
& 2 more
-
Employee Count
1
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CRIL
CRIL offers a comprehensive portfolio of products and services, including STRALE, CHAMP, and CORAL.
Ultra-fast laser for coherent Raman imaging in tissue analysis.
Advanced tool for high-speed label-free cell diagnostics.
Platform for AI-assisted Raman scattering microscopy applications.
Funding Insights of CRIL
CRIL has successfully raised a total of $1.7M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $1.38 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CRIL
CRIL has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Frontier IP, European Union and Graphene Flagship.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Asset management consulting services are provided by Frontier IP.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Research and innovation in graphene and 2D materials are facilitated.
|
Locked | Locked | Locked |
Investor details for CRIL
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CRIL
Investment portfolio details for CRIL
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CRIL
Detailed financials for CRIL
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cril Comparisons
Peer comparison for CRIL
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CRIL
CRIL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology tools and systems for molecular scale are developed.
|
|
| Locked | Locked | Locked |
Imaging solutions for macro, micro, and nano structures are provided.
|
|
| Locked | Locked | Locked |
Innovative solutions for cancer treatment and industrial applications are provided by IBA.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| Locked | Locked | Locked |
Microfluidics-based tools for cellular analysis are provided.
|
Detailed competitors of CRIL
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cril
Complete news archive for CRIL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CRIL
CRIL was founded in 2018 and raised its 1st funding round 2 years after it was founded.
CRIL is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
CRIL is a funded company, having raised a total of $1.7M across 8 funding rounds to date.
As of Jan 31, 2022, the latest employee count at CRIL is 1.
CRIL was founded in 2018 in Cambridge, United Kingdom. Devices incorporating AI for cell analysis and tissue diagnosis are developed by the company within the biotechnology sector. The Coherent Raman Platform serves as a digital imaging tool to assess images used in diagnosis, cellular process evaluation, drug discovery, and therapy monitoring. Operations center on medical imaging applications for research and clinical settings.
CRIL's top competitors include Oxford Instruments, Scholar Rock and Leica Microsystems.
CRIL offers STRALE, CHAMP, and CORAL.
CRIL has 3 investors. Key investors include Frontier IP, European Union, and Graphene Flagship.